73 results found.
      
Enabling Technology and Integrated Selling Strategies Drove Orthopedic Growth in the Third Quarter
The third quarter of 2019 brought some standout performances from large players like Stryker, Medtronic, NuVasive and Globus Medical. DePuy Synthes and Zimmer Biomet made incremental progress in returning to market growth. Notably, the top performing players all have well-established enabling tec...
OrthoPediatrics Launches PediFoot Deformity Correction in the U.S.
OrthoPediatrics commenced commercial U.S. launch of the PediFoot Deformity Correction System.
OrthoPediatrics Records Highest Revenue Quarter in Company History
OrthoPediatrics reports 3Q19 revenue of USD $20.7MM, +31.1% vs. 3Q18.
Orthopedic Public Companies Grow 2.6% YoY in Quarter
By Mike Evers The second quarter of 2019 brought incremental improvement over the first. Year over year revenue grew 2.6% in the quarter for the public companies reported herein compared to 1.1% last quarter. The five largest orthopedic players, which control 58% of the market, showed a...
OrthoPediatrics Launches Next-Gen Cannulated Screws
OrthoPediatrics launched next-generation Cannulated Screw systems in the U.S. to treat pediatric fractures and fusions.
OrthoPediatrics Gains FDA Clearance for PediFoot Deformity Correction
OrthoPediatrics received FDA 510(k) clearance to market the PediFoot Deformity Correction system. Product launch is slated for 3Q19.
OrthoPediatrics Continues Record Growth in 2Q19
OrthoPediatrics reports 2Q19 revenue of USD $18.2MM, +20.7% vs. 2Q18.
OrthoPediatrics Gains FDA Clearance for Next-Generation Cannulated Screw
OrthoPediatrics received FDA 510(k) clearance to market its next-generation Cannulated Screw to treat smaller stature patients.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
OrthoPediatrics Acquires Vilex, ExFix Technology
OrthoPediatrics acquired Vilex, with its Orthex Hexapod circular fixation technology and x-ray planning software...
OrthoPediatrics Reports 1Q19 Revenue of $14.7MM, +21.2% vs. 1Q18
OrthoPediatrics reports 1Q19 revenue of USD $14.7MM, +21.2% vs. 1Q18.
OrthoPediatrics/CoorsTek Medical Licensing Partnership
OrthoPediatrics entered into an agreement with CoorsTek Medical for rights to sublicense its Variable-Angle technolo...
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
OrthoPediatrics reports 4Q18 revenue of USD $14.6MM, +24.7% vs. 4Q17, with 2018 full year revenue of $57.6MM, +26.2% vs. 2017.
OrthoPediatrics reports 4Q18 revenue of USD $14.6MM, +24.7% vs. 4Q17, with 2018
OrthoPediatrics Launches BandLoc DUO
OrthoPediatrics introduced BandLoc DUO, the latest addition to the BandLoc 5.5/6.0mm spinal repair system.
AAOS Preview: First-Time Exhibitors, New Offerings on the Exhibit Floor
By Julie A. Vetalice The American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting is taking place March 12-16 in Las Vegas. The popular destination is expected to draw ~4,000 more attendees (total of ~30,000) and more exhibitors (~650) than last year’s meeting in New Orleans...
Orthofix Acquires Distributor, Options Medical
Orthofix Medical acquired Options Medical, a former distributor of OFIX Bone Growth Therapies.
ConforMIS, Orthofix and OrthoPediatrics Report Preliminary 4Q18 and FY 2018 Results
Preliminary results for ConforMIS, Orthofix and OrthoPediatrics were mixed. While ConforMIS’ net revenue for the year grew in the double digits, adjusting for product-only revenue reveals a mostly flat year. Orthofix rode strong spinal implant sales to mid-...
OrthoPediatrics Expands Direct Sales in Belgium, the Netherlands
OrthoPediatrics updated an agreement with Hospithera to act as its exclusive sales agency in Belgium and the Netherlands...
OrthoPediatrics' Launch of RESPONSE 4.5/5.0mm System
OrthoPediatrics commenced full U.S. launch of the RESPONSE 4.5/5.0mm system for the treatment of complex scoliosis
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
OrthoPediatrics Reports 3Q18 Revenue of $15.8MM, +27.8% vs. 3Q17
OrthoPediatrics continues growth with another quarter of record revenues, reports US $15.8MM in 3Q18 sales, +...
OrthoPediatrics Gains FDA Clearance for Small Stature Scoliosis System
OrthoPediatrics received FDA 510(k) clearance to market the RESPONSE 4.5/5.0mm system to treat complex scoliosis...
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group